v3.26.3
Segments (Tables)
9 Months Ended
Sep. 30, 2026
Single Reportable Segment  
Segment Reporting [Line Items]  
Schedule of Significant Segment Expenses Regularly Provided to the CODM

The following table presents certain significant segment expenses that are regularly provided to the CODM (in thousands):

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Research and development expenses:

 

 

 

 

 

 

 

 

 

 

 

GlyphAllo direct research and development expenses

$

10,189

 

 

$

7,698

 

 

$

31,283

 

 

$

15,757

 

GlyphAgo direct research and development expenses

 

3,400

 

 

 

4,214

 

 

 

13,373

 

 

 

8,185

 

Glyph2BLSD direct research and development expenses

 

3,173

 

 

 

3,241

 

 

 

5,372

 

 

 

5,688

 

Nonclinical and early discovery assets

 

1,837

 

 

 

978

 

 

 

4,190

 

 

 

2,766

 

Personnel-related (including non-cash stock-based compensation expense of $1.0 million and $0.6 million for three months ended September 30, 2026 and 2025, respectively and $2.7 million and $1.7 million for nine months ended September 30, 2026 and 2025, respectively)

 

4,651

 

 

 

3,822

 

 

 

13,981

 

 

 

10,693

 

Other indirect research and development expenses

 

641

 

 

 

500

 

 

 

1,740

 

 

 

1,306

 

Total research and development expenses

 

23,891

 

 

 

20,453

 

 

 

69,939

 

 

 

44,395

 

General and administrative expenses:

 

 

 

 

 

 

 

 

 

 

 

Personnel-related (including non-cash stock-based compensation expense of $1.5 million and $1.2 million for three months ended September 30, 2026 and 2025, respectively and $39.1 million and $3.5 million for nine months ended September 30, 2026 and 2025, respectively)

 

3,848

 

 

 

3,179

 

 

 

46,140

 

 

 

9,440

 

Other general and administrative expenses(1)

 

2,606

 

 

 

1,809

 

 

 

7,616

 

 

 

6,260

 

Total general and administrative expenses

 

6,454

 

 

 

4,988

 

 

 

53,756

 

 

 

15,700

 

Other segment items(2)

 

(3,951

)

 

 

(2,897

)

 

 

(9,293

)

 

 

(9,349

)

Net loss

$

26,394

 

 

$

22,544

 

 

$

114,402

 

 

$

50,746

 

 

(1)
Other general and administrative expenses include professional fees, facilities, depreciation, IT, and other expenses.
(2)
Other segment items include interest income, net, research and development tax credit, income tax provision, and other income (expense), net.